Bvf Inc I Teos Therapeutics, Inc. Transaction History

Bvf Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$10.95 - $14.6 $6.04 Million - $8.05 Million	-551,359 Reduced 30.45%	1,259,476 $13.8 Million
Q3 2022 Nov 14, 2022	SELL	$18.6 - $27.25 $2.2 Million - $3.23 Million	-118,366 Reduced 6.14%	1,810,835 $34.5 Million
Q2 2022 Aug 15, 2022	BUY	$16.57 - $35.1 $8.77 Million - $18.6 Million	529,000 Added 37.78%	1,929,201 $39.7 Million
Q1 2022 May 16, 2022	BUY	$31.92 - $47.45 $44.7 Million - $66.4 Million	1,400,201 New	1,400,201 $45.1 Million

165

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $293M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.